argenx's Vygart Hytrulo Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
CompanyDrug

argenx’s Vygart Hytrulo Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy

Daiichi Sankyo's Datroway Approved in Japan for HR+, HER2- Breast Cancer
CompanyDrug

Daiichi Sankyo’s Datroway Approved in Japan for HR+, HER2- Breast Cancer

MabPharm's CMAB807 Biosimilar Receives Market Approval in Indonesia and Peru
CompanyDrug

MabPharm’s CMAB807 Biosimilar Receives Market Approval in Indonesia and Peru

Shanghai Ark Biopharmaceutical Partners with Partex to Advance AI-Driven Drug Development
CompanyDeals

Shanghai Ark Biopharmaceutical Partners with Partex to Advance AI-Driven Drug Development

Zhongheng Group and Fosun Pharmaceutical Form JV to Boost Overseas Business
CompanyDeals

Zhongheng Group and Fosun Pharmaceutical Form JV to Boost Overseas Business

BeiGene's Tevimbra Receives FDA Approval for HER2-Negative Gastric Cancer Treatment
CompanyDrug

BeiGene’s Tevimbra Receives FDA Approval for HER2-Negative Gastric Cancer Treatment

Huadong Medicine Partners with SynerK PharmaTech for Hypertension siRNA Drug Development
CompanyDeals

Huadong Medicine Partners with SynerK PharmaTech for Hypertension siRNA Drug Development

NMPA Releases 87th Batch of Reference Drugs for Generic Quality Consistency
Policy / Regulatory

NMPA Releases 87th Batch of Reference Drugs for Generic Quality Consistency

Bristol-Myers Squibb's Opdivo Qvantig Receives FDA Approval for Expanded Indications
CompanyDrug

Bristol-Myers Squibb’s Opdivo Qvantig Receives FDA Approval for Expanded Indications

HitGen Inc. Initiates Phase II Clinical Trial for HG146 in Adenoid Cystic Carcinoma
CompanyDrug

HitGen Inc. Initiates Phase II Clinical Trial for HG146 in Adenoid Cystic Carcinoma

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion
CompanyDeals

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion

Xtalpi Inc. Partners with NCCS and Duke-NUS to Advance AI-Driven Drug Discovery
CompanyDeals

Xtalpi Inc. Partners with NCCS and Duke-NUS to Advance AI-Driven Drug Discovery